Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.

This study has an unknown status. It is testing Safety, Tolerability and Efficacy of Psilocybin-Assisted Psychotherapy for depression.
Current recruitment is not confirmed. Check the official registry or contact the research team before making plans to participate.
Then choose your country and confirm availability with each study site.
This summary needs review. Please check the official study record and contact the research team for details.
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)This record does not confirm open recruitment. We can help you understand it and explore other studies.
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
View official study record (opens in a new tab)No specific site is confirmed in the available information. Check the official source for locations and remote participation.
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Confirm the location and whether remote participation is possible with the research team.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Based on the public registry summary, this study is trying to understand: Post-Traumatic Stress Disorder (PTSD) is a mental disorder that may develop in people who have been exposed to a traumatic event, including actual or threatened death, serious injury, or sexual violence. Exposure to a traumatic event is defined as directly experiencing the. The study team can confirm the exact objective and what it means for you.
This appears to be a medication / drug study involving APEX-002-A02, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
This study may concern people with depression; age range: From 18 Years to 65 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
This study is sponsored by Apex Labs Ltd., which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Current recruitment is not confirmed. Check the official registry or contact the research team before making plans to participate.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me